2018
-
The IASLC Fight Against Lung Cancer in Peru and Latin America
By Dr. Luis E. Raez, MD Posted: October 2018 Peru is one of the largest Latin American countries, with a population of approximately 28 million people. Cancer is not yet […]
-
KEYNOTE-042: No Hard and Fast Rules for First-Line Pembrolizumab Regarding PD-L1–Positive Disease
By Kara Nyberg, PhD Posted: August 2018 The pace of research focused on new therapies for advanced NSCLC has progressed from a trot to a sprint in recent years. Among […]
-
Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research
By Caroline Dive, CBE, PhD, FMedSci, and Kris Frese, PhD Posted: August 2018 Small cell lung cancer (SCLC) is aggressive, disseminates early, and has a dismal prognosis.1 Its genomic landscape […]
-
NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy
Posted: August 2018 In October 2017, the United States National Cancer Institute (NCI) launched a major effort to expand the discovery and validation of predictive biomarkers on cancer immunotherapy. This […]
-
The Budget Landscape with Dr. Douglas R. Lowy
By Erik MacLaren, PhD Posted: August 2018 The National Cancer Institute (NCI) and researchers who rely on the funding it provides have spent much of the past year under the […]
-
The IASLC Issues Liquid Biopsy Statement to Aid Understanding of Rapid Innovation
By Joy Curzio Posted: August 2018 Liquid biopsy is a powerful tool that can determine a patient’s molecular tumor profile and aid diagnosis, as well as therapeutic choices. Liquid biopsy […]
-
Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma
By Hedy L. Kindler, MD Posted: August 2018 The American Society of Clinical Oncology (ASCO) has issued its first-ever clinical practice guidelines on the management of patients with malignant pleural […]
-
Updated Results from the Phase III ALEX Trial: Embracing Hazard Ratios
By D. Ross Camidge, MD, and Mary W. Redman, PhD Posted: August 2018 Updates of the primary analysis of the phase III ALEX trial were presented at the American Society […]
-
WCLC Plenary Symposia to Include Practice-Changing Research Presentations
The conference’s program is stacked with science and education for scientists, clinicians, and advocates alike. By Leah K. Lawrence Posted: August 2018 The IASLC 19th World Conference on Lung Cancer […]
-
Avrum Spira, MD
Posted: August 2018 Avrum Spira, MD, has been named global head of the new Lung Cancer Initiative within Johnson & Johnson, which will be based at Boston University’s Medical Campus. […]
View ILCN Archives
Provider Resources